Philogen to attend the 3rd Annual Cytokine-Based Drug Development Summit, Boston (July 26-29, 2022)

Philogen will attend the 3rd Annual Cytokine-Based Drug Development Summit in Boston.

Roberto De Luca, Head of Antibody Therapeutics, will give a virtual lecture entitled “Antibody-cytokine fusion proteins against Fibroblast Activation Protein (FAP)” on the 28 of July.

Please visit the Summit Website for more details.